Back to News

Xencor joins IQ Consortium

Xencor joins IQ Consortium

April 19, 2022


The IQ Consortium is proud to announce Xencor to its membership. 

Xencor is expanding the therapeutic boundaries of antibody and cytokine drugs and has offices in California, USA. 

Xencor will be represented on the IQ Board of Directors by Norm Barlow and Jitendra Kanodia.